FDA Person
Office of Inspections and InvestigationsJeffrey P. Raimondi
View detailed information about Jeffrey P. Raimondi, including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of Inspections and Investigations. Took part in 84 inspections of 82 companies, 2016–2026.
Inspections (84)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 4, 2026 | Indoco Remedies Limited | Not classified | #1337390 | |
| August 25, 2026 | Cipla Limited | Not classified | #1331746 | |
| July 3, 2026 | Alkem Laboratories Limited | Not classified | Generic Drug Evaluation | #1325062 |
| June 19, 2026 | Felix Generics Private Limited | Not classified | Pre-Approval Eval. of Animal Drugs and Food Additives | #1322712 |
| April 17, 2026 | Cipla Limited | Not classified | Drug Quality Assurance | #1313374 |
| April 3, 2026 | Symbiotec Pharmalab Private Limited | Not classified | #1313542 | |
| January 23, 2026 | MSD International GmbH (Singapore Branch) | Not classified | #1299886 | |
| December 11, 2025 | Life Science Outsourcing, Inc. | VAI | Drug Quality Assurance | #1294966 |
| November 6, 2025 | Emballages Spectrum Inc. | Not classified | Generic Drug Evaluation | #1291080 |
| November 3, 2025 | Jubilant HollisterStier General Partnership | OAI | Drug Quality Assurance | #1289886 |
| September 29, 2025 | Lonza Manufacturing LLC | Not classified | #1287278 | |
| August 15, 2025 | Cardinal Health | VAI | Drug Quality Assurance | #1278538 |
| June 27, 2025 | NerPharMa S.r.l. | Not classified | Drug Quality Assurance | #1273996 |
| May 9, 2025 | Ajinomoto Althea, Inc. | VAI | Drug Quality Assurance | #1266794 |
| March 26, 2025 | Creative Essences Inc. | VAI | Drug Quality Assurance | #1264932 |
| March 25, 2025 | Creative Essences Inc | OAI | Drug Quality Assurance | #1264931 |
| March 18, 2025 | Vege Labs LLC | VAI | Drug Quality Assurance | #1262141 |
| January 24, 2025 | Zhejiang Huahai Pharmaceutical Co., Ltd. | OAI | Drug Quality Assurance | #1259818 |
| January 14, 2025 | Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) | Not classified | #1259422 | |
| December 6, 2024 | Dynamic Blending Specialists, Inc. | OAI | Drug Quality Assurance | #1255959 |
Documents (71)
- 483 · First Pharma Associates LLC dba Riverpoint Pharmacy · June 7, 2019
- 483 · Apitoria Pharma Private Limited · August 2, 2022
- 483 · Zhejiang Huahai Pharmaceutical Co., Ltd. · April 16, 2025
- 483 · Optum Compounding Services, LLC · August 13, 2021
- 483 · Wedgewood Connect, LLC · November 17, 2023
- 483 · Constant Irwindale, Inc. · November 15, 2024
- 483 RESPONSE · Wedgewood Connect, LLC · November 17, 2023
- WARNING LETTER RESPONSE · Invacare Corporation · January 11, 2011
- WARNING LETTER RESPONSE · Invacare Corporation · March 18, 2011
- WARNING LETTER RESPONSE · Invacare Corporation · June 10, 2011
- 483 · Biocon Sdn. Bhd. (Company No. 201101002193) · September 27, 2024
- EIR · Cosmetic Enterprises Ltd · June 11, 2021
- 483 · Lonza Manufacturing LLC · September 29, 2025
- 483 · Cardinal Health, Inc. · August 15, 2025
- 483 · Fresh Farms LLC · November 11, 2021
- 483 · Panacea Biotec Pharma Limited · February 20, 2020
- 483 · UCLA Biomedical Cyclotron · July 31, 2020
- 483 · Indoco Remedies Limited · February 28, 2023
- 483 · Allure Labs, Inc. · November 23, 2020
- 483 · Ajinomoto Althea, Inc. · May 9, 2025
- 483 · Life Science Outsourcing, Inc. · December 11, 2025
- 483 · Emballages Spectrum Inc. · November 6, 2025
- 483 · Vege Labs LLC · March 18, 2025
- 483 · Creative Essences Inc. · March 26, 2025
- EIR · Boehringer Ingelheim Fremont, Inc. · November 4, 2022
- 483 · Cardinal Health · August 15, 2025
- 483 · PharmaEssentia Corporation, Taichung Plant
- 483 · Alcon Singapore Manufacturing Pte Ltd. · September 8, 2023
- 483 · Element Materials Technology Oakland-Concord · March 22, 2022
- 483 · Sun Pharmaceutical Industries Limited · February 7, 2020
- 483 · Nectar Lifesciences Limited · March 10, 2023
- 483 · Weckerle Cosmetics USA, INC · March 26, 2021
- 483 · Zhuhai Rundu Pharmaceutical Co Ltd
- 483 · DLC Laboratories, Inc · December 12, 2019
- 483 · Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)
- 483 · Excelvision · July 7, 2023
- 483 · Intarcia Therapeutics, Inc. · January 17, 2020
- 483 · Hetero Labs Limited (Unit V) · August 12, 2022
- 483 · Jubilant Generics Limited · February 2, 2024
- 483 · Oxalis Labs · August 2, 2019
- 483 · U.S. Continental Marketing, Inc. · March 18, 2021
- 483 · Boehringer Ingelheim Fremont, Inc. · November 4, 2022
- 483 · Jubilant HollisterStier General Partnership · November 3, 2025
- 483 · Dynamic Blending Specialists, Inc. · December 6, 2024
- 483 · Creative Essences Inc · March 25, 2025
- 483 · Steriscience Specialties Private Limited · March 28, 2024
- 483 · Custom Research Labs Inc · June 4, 2021
- 483 · NuGeneration Technologies, LLC · September 22, 2022
- 483 · Intas Pharmaceuticals Ltd. · January 24, 2024
- 483 · NerPharMa S.r.l. · June 27, 2025
- 483 · DSP Skin Care LLC · September 9, 2021
- 483 · Cosmetic Enterprises Ltd · June 11, 2021
- 483 · Panacea Biotec Pharma Limited · August 9, 2019
- 483 · Packaging On Demand, Inc. · January 13, 2023
- 483 · Gland Pharma Limited, Units I+II Pashamylaram Site · August 2, 2024
- 483 · NerPharMa S.r.l. · June 19, 2024
- 483 · Kari Gran Inc. · July 8, 2022
- 483 · Intas Pharmaceuticals Limited · January 24, 2024
- 483 · MSD International GmbH (Singapore Branch) · January 23, 2026
- 483 · PharmaEssentia Corporation, Taichung Plant · April 18, 2023
- 483 · Zhejiang Huahai Pharmaceutical Co., Ltd. · January 24, 2025
- 483 · Cipla Limited · April 17, 2026
- 483 · Gland Pharma Limited · July 25, 2024
- 483 · Cosmecca Korea Co., Ltd. · September 13, 2024
- 483 · Alkem Laboratories Limited · July 3, 2026
- 483 · Apotex Research Private Limited · March 15, 2024
- 483 · Beijing Zhangguang 101 Science & Technology Co., Ltd.
- 483 · Cipla Limited · August 25, 2026
- 483 · Symbiotec Pharmalab Private Limited
- 483 · Par Formulations Private Limited · June 25, 2026
- 483 · Indoco Remedies Limited · September 4, 2026
Frequently inspected with (10)
Linda F. Murphy
SVP Consulting & Operations
5 shared
Anney Lin
Statistical Science Director
4 shared
Roger F. Zabinski
Investigator
4 shared
Anastasia M. Shields
Consumer Safety Officer
3 shared
Joshua P. Wireman
Investigator
3 shared
Scott N. Lim
3 shared
Truong X. Nguyen
Investigator
3 shared
Uttaniti Limchumroon
3 shared
Xiaokuang Lai
3 shared
Aranjeet Singh
FDA_PERSONNEL
2 shared
Related Office
Person Information
Name
Jeffrey P. Raimondi
Title
Consumer Safety Officer
Role
INVESTIGATOR
ID: 7576ca4e-d9e8-4015-9ae6-9498e76058d3
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.